Erratum to: Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumors
Cancer Chemother Pharmacol
.
2016 Nov;78(5):969.
doi: 10.1007/s00280-016-3159-7.
Authors
Martin J Edelman
1
,
Rena Lapidus
2
,
Josephine Feliciano
2
,
Miroslav Styblo
3
,
Jan H Beumer
4
5
6
,
Tao Liu
7
,
Jogarao Gobburu
7
Affiliations
1
University of Maryland Greenebaum Cancer Center, 22 S. Greene Street, Baltimore, MD, 21201, USA. medelman@umm.edu.
2
University of Maryland Greenebaum Cancer Center, 22 S. Greene Street, Baltimore, MD, 21201, USA.
3
Department of Nutrition, University of North Carolina, Chapel Hill, NC, USA.
4
Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
5
Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, USA.
6
Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
7
University of Maryland School of Pharmacy, Baltimore, MD, USA.
PMID:
27677624
DOI:
10.1007/s00280-016-3159-7
No abstract available
Publication types
Published Erratum